Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (6): 634-641.doi: 10.3736/jcim20070607

Special Issue: Traditional Chinese Medicine

• Original Experimental Research • Previous Articles     Next Articles

Establishment of Caco-2 cell monolayer model and standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine

Xiu-wei Yang, Xiao-da Yang, Ying Wang, Lian Ma, Yue Zhang, Xiao-gai Yang, Kui Wang   

  1. State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100083,China
  • Online:2007-11-20 Published:2007-11-15

Objective: To establish Caco-2 (a human colon adenocarcinoma cell line) cell monolayer model and the standard operation procedure for studying and assessing intestinal absorption of chemical components of traditional Chinese medicine.Methods: Caco-2 cell monolayer model was established and evaluated by morphology feature using scanning electron microscope, inverted microscope and transepithelial electrical resistance (TEER) assay. Additionally, the model was further tested for the activity of alkaline phosphatase and the apparent permeability (Papp) of standard compounds, i.e. propranolol and atenolol, which were the control substances for high and poor transcellular transport marker, respectively.Results: The integrality of cell monolayer, cell differentiation (reflected by expression of alkaline phosphatase and cell monolayer morphology), and the Papp value of standard compounds in the established Caco-2 cell model were satisfactory. All parameters tested were in good agreement with those reported in the literature.Conclusion: The established Caco-2 cell model can be used to study the intestinal absorption of orally administrated chemical components of traditional Chinese medicine and their absorption mechanism.

Key words: Caco-2 cells, Chinese herbal drugs, intestinal absorption, biological transport

CLC Number: 

  • R348

Figure 1

Diagram of Transwell and transport experiment"

Figure 2

Apical side of Caco-2 monolayer (scanning electron micrograph)"

Figure 3

Characteristic microvilli of apical side of the differentiated Caco-2 monolayer (transmission electron micrograph)"

Figure 4

Tight junction-desmosome of Caco-2 monolayer (transmission electron micrograph)"

[1] 杨秀伟 . 基于体内过程的中药有效成分和有效效应物质的发现策略[J]. 中国中药杂志, 2007,32(5):365-370
Yang XW . Discovery strategy for effective and active constituents of Chinese material medica based on the processes of metabolism and disposition in intra-body[J]. Zhongguo Zhong Yi Yao Za Zhi, 2007,32(5):365-370
[2] 杨秀伟 . 基于体内过程的中药毒性成分和毒性效应物质的发现策略[J]. 中华中医药杂志, 2007,22(2):67-72
Yang XW . Discovery strategy for toxic-invited constituents and toxic-effective substances on Chinese material medica based on the processes of metabolism and disposition in intra-body[J]. Zhong Hua Zhong Yi Yao Za Zhi, 2007,22(2):67-72
[3] 杨秀伟 . 中药实验医学研究中的关键基础科学问题[J]. 中西医结合学报, 2005,3(2):154-159
Yang XW . Key foundational science problem in experimental medicine study of Chinese materia medica: ascertainment of active and toxic constituents in Chinese materia medica[J]. Zhong Xi Yi Jie He Za Zhi, 2005,3(2):154-159
[4] 杨秀伟 . 中药成分的肠内和肝内行为与中药有效成分的确定[J]. 中草药, 2004,35(增刊):1-5
Yang XW . Relationship between confirmation of Chinese materia medica bioactive constituents and intra-intestinal and intra-hepatic behavior of Chinese materia medica active constituents[J]. Zhong Cao Yao, 2004,35(Suppl):1-5
[5] 杨秀伟, 郝美荣, 服部征雄 . 中药成分代谢分析[M]. 北京: 中国医药科技出版社,2003.
Yang XW, Hao MR Hattori M, , . Metabolite analysis for chemical constituents of traditional Chinese medicines[M]. Beijing: China Medical-Pharmaceutical Science & Technology Publishion House, 2003.
[6] 周昕 . 药物吸收体外研究方法的概述[J]. 中国临床药理学与治疗学, 2006,11(4):379-384
Zhou X . Study on in vitro models of drug absorption[J]. Zhongguo Lin Chuang Yao Li Xue Yu Zhi Liao Xue, 2006,11(4):379-384
[7] Turowski GA, Rashid Z, Hong F , et al. Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines[J]. Cancer Res, 1994,54(22):5974-5980
doi: 10.1002/1097-0142(19941115)74:10<2885::AID-CNCR2820741023>3.0.CO;2-P pmid: 7954430
[8] Rashid Z, Basson MD . Topoisomerase II inhibition differentially modulates Caco-2 intestinal epithelial cell phenotype[J]. Biochem Biophy Res Comm, 1996,219(1):82-88
[9] Yee SY . In vitro permeability across Caco-2 cells(colonic) can predict in vivo(small intestinal) absorption in man-fact or myth[J]. Pharm Res, 1997,14(6):763-766
[10] Chong S, Dando SA, Morrison RA . Evaluation of biocoat intestinal epithelium differentiation environment(3-day cultured Caco-2 cells) as an absorption screening model with improved productivity[J]. Pharm Res, 1997,14(12):1835-1837
[11] Gao JN, Hugger ED, Beck-Westermeyer MS , et al.Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayer. In ‘Current Protocols in Pharmacology.[M].Chichester:John Wiley & Sons, 2000.
[12] Walle UK, French KL, Walgren RA , et al. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: Potential role for MRP2[J]. Res Commun Mol Pathol Pharmacol, 1999,103(1):45-46
doi: 10.1159/000028443 pmid: 10440570
[13] Tian XJ, Yang XD, Wang K , et al. The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2[J]. Pharm Res, 2006,23(8):1721-1728
[14] Yang XW, Guo QM, Wang Y , et al. Intestinal permeability of antivirus constituents from the fruits of Eucalyptus globulus Labill. in Caco-2 cell model[J]. Bioorg Med Chem Lett, 2007,17(4):1107-1111
[15] 田莉, 杨秀伟, 王莹 , 等. 顺式-和反式-阿霍烯在Caco-2细胞模型中的体外摄取、转运和外排特性[J]. 药学学报, 2007,42(1):87-92
Tian L, Yang XW, Wang Y , et al. Characteristics of uptake, transport and efflux of Z- and E-ajoenes in Caco-2 cell monolayers in vitro[J]. Yao Xue Xue Bao, 2007,42(1):87-92
[16] Yang XG, Yuan Lan, Wang K , et al. Comparison of intestinal absorption of two insulinmimic vanadyl complexes using Caco-2 monolayers as model system[J]. Chin Sci Bull, 2003,48(9):876-881
[17] Zhang Y, Yang XD, Wang K , et al. The permeability and cytotoxicity of insulin-mimetic vanadium(III, IV, V)-dipicolinate complexes[J]. J Inorg Biochem, 2006,100(1):80-87
[18] Bohets H, Annaert P, Mannens G , et al. Strategies for absorption screening in drug discovery and development[J]. Curr Top Med Chem, 2001,1(5):367-383
doi: 10.2174/1568026013394886 pmid: 11899103
[19] 张正全, 陆彬 . 口服结肠定位给药系统新进展[J]. 中国药学杂志, 2000,35(1):221-223
Mu YP, Wu G, Qiao XW , et al. The transport and absorption of chiral metal domplexes d,l-[Ni(phen)3]2+ across the model of Caco-2 cell monolayers[J]. Baotou Yi Xue Yuan Xue Bao, 2000,35(1):221-223
[20] Komura H, Shigemoto Y, Kawahara I , et al. High throughput screening of pharmacokinetics and metabolism in drug discovery(III)--investigation on in- silico model for membrane permeability and CYP1A2 inhibition[J]. Yakugaku Zasshi, 2005,125(1):141-147
[21] 牟永平, 吴刚, 乔秀文 , 等. 手性金属配合物d,l-[Ni(phen)3]2+ 经Caco-2细胞单层模型的吸收转运[J]. 包头医学院学报, 2006,22(4):358-360
Mu YP, Wu G, Qiao XW , et al. The transport and absorption of chiral metal domplexes d,l-[Ni(phen)3]2+ across the model of Caco-2 cell monolayers[J]. Baotou Yi Xue Yuan Xue Bao, 2006,22(4):358-360
[22] Schmiedlin-Ren P, Thummel KE, Fisher JM , et al. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3[J]. Mol Pharmacol, 1997,51(5):741-754
[23] Annaert P, Kinget R, Naesens L , et al. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa(Caco-2)[J]. Pharm Res, 1997,14(4):492-496
[24] van Gelder J, Annaert P, Naesens L , et al. Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study[J]. Pharm Res, 1999,16(7):1035-1040
[25] Bartels H, Korsiak E,Daniel H . Transport activity of the MDR1-gene product in monolayers of Caco-2 cells[J].Zeitschrift fur Gastroenterologie, 1994, 32 15-18
[26] Dibas A, Wood J, Mia AJ et al.The ATP-depleting reagent iodoacetamide induces the degradation of protein kinase C alpha(PKCalpha) in LLC-PK1 pig kidney cells[J]. Life Sci, 1997,61(17):1697-1704
[27] Tsuruo T, Iida H, Tsukagoshi S , et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil[J]. Cancer Res, 1981,41(5):1967-1972
[28] Roepe PD . The P-glycoprotein efflux pump: how does it transport drugs?[J]. J Membr Bio, 1997,160(3):161-175
[29] Leier I, Jedlitschky G, Buchholz U , et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates[J]. J Biol Chem, 1994,269(45):27807-27810
[30] Jedlitschky G, Leier I, Buchholz U . ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein[J]. Cancer Res, 1994,54(18):4833-4836
[31] Barrand MA, Bargrij T, Neo SY . Multidrug resistance-associated protein: A protein distinct from P-glycoprotein involved in cytotoxic drug expulsion[J]. Gen Pharmacol, 1997,28(5):639-645
[32] Chen J, Lin H, Hu M . Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model[J]. Cancer Chemother Pharmacol, 2005,55(2):159-169
[33] Nikolic D, Li Y, Chadwick LR , et al. In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops(Humulus lupulus L.)[J]. Pharm Res, 2006,23(5):864-872
[1] Ming-hui Yang, Min Li, Yong-qi Dou, Yi Liu, Xiao-dong Luo, Jian-zong Chen, Heng-jun Shi. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: A multicenter, randomized, double-blind and placebo-controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(3): 231-237.
[2] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047.
[3] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052.
[4] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059.
[5] Li Yan, Xian-chuan Chen, Jian Guo, Li-li Qi, Yi-ming Qian, Xiong-gen Zhou. Prevention of hospital-acquired pneumonia with Yupingfeng Powder in patients with acute cerebral vascular diseases: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(1): 25-29.
[6] Wen-jun Wang, Da-jin Li, Jun Li, Wen-jiang Zhou. An in vitro study on neuroprotective effects of serum containing Gengnianchun decoction and its main monomers against amyloid beta protein-induced cellular toxicity. Journal of Chinese Integrative Medicine, 2010, 8(1): 67-73.
[7] Xin-yue Zhi . Traditional Chinese medicine diagnosis and treatment of type 2 diabetes in Tianjin urban population. Journal of Chinese Integrative Medicine, 2009, 7(9): 823-826.
[8] Xin-jun Liu, Shi-bing Su. Study of combination methods for formula composition of Chinese herbal medicines and their components. Journal of Chinese Integrative Medicine, 2009, 7(7): 601-606.
[9] Deng-hao Liu, Zheng Wang, Zhang-yan Qin. Clinical effects of Shugan Jianpi Recipe on postadolescent acne in women. Journal of Chinese Integrative Medicine, 2009, 7(7): 671-673.
[10] Ai-ping Lu, Xue-wen Liu, Xiao-rong Ding. Methodology of pharmacodynamic evaluation on Chinese herbal medicine based on syndrome differentiation. Journal of Chinese Integrative Medicine, 2009, 7(6): 501-504.
[11] Xian-jun Tong, Xiao-yu Xiang, Zun-hua Cheng, Li Chen, Xian-chuan Chen, Jing-xian Chen. Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower limb arteriosclerosis: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(6): 518-521.
[12] Jia Guo , Rui-ming Zhang, Zong-wen Huang, Lei Wang, Song-shan Liu, Jun-cheng Diao, Si-yuan Hu, Bing-hui Lin. Yunchang Capsule in treatment of functional constipation: A randomized, double-blinded controlled, multicenter trial. Journal of Chinese Integrative Medicine, 2009, 7(12): 1123-1129.
[13] Wen Cao, Ai-guang Zhao . Prescription rules of Chinese herbal medicines in treatment of gastric cancer. Journal of Chinese Integrative Medicine, 2009, 7(1): 1-8.
[14] Chung-wah Cheng, Zhao-xiang Bian, You-ping Li, David Moher, Tai-xiang Wu, Simon Dagenais, Jing Li, Ting-qian Li. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials. Journal of Chinese Integrative Medicine, 2008, 6(9): 881-886.
[15] Zhao-xiang Bian, David Moher, You-ping Li, Tai-xiang Wu, Simon Dangenais, Chung-wah Cheng, Jing Li, Ting-qian Li. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(8): 771-775.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[7] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[8] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[9] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[10] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92